Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00084318 · BASELINE

Baseline characteristics

Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck · Source last updated 2018-12-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      97
    2. group Id
      BG001
      value
      106
    3. group Id
      BG002
      value
      203
    units
    Participants
groups
  1. description
    Loading dose of cetuximab followed by radiation therapy with weekly cisplatin and cetuximab.
    id
    BG000
    title
    RT + Cisplatin + Cetuximab
  2. description
    Loading dose of cetuximab followed by radiation therapy (RT) with weekly docetaxel and cetuximab.
    id
    BG001
    title
    RT + Docetaxel + Cetuximab
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          27
          upper Limit
          80
          value
          57
        2. group Id
          BG001
          lower Limit
          21
          upper Limit
          79
          value
          55
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          80
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          32
        3. group Id
          BG002
          value
          52
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          77
        2. group Id
          BG001
          value
          74
        3. group Id
          BG002
          value
          151
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who started protocol treatment and did not withdraw consent.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      97
    2. group Id
      BG001
      value
      106
    3. group Id
      BG002
      value
      203
    units
    Participants
groups
  1. description
    Loading dose of cetuximab followed by radiation therapy with weekly cisplatin and cetuximab.
    id
    BG000
    title
    RT + Cisplatin + Cetuximab
  2. description
    Loading dose of cetuximab followed by radiation therapy (RT) with weekly docetaxel and cetuximab.
    id
    BG001
    title
    RT + Docetaxel + Cetuximab
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          27
          upper Limit
          80
          value
          57
        2. group Id
          BG001
          lower Limit
          21
          upper Limit
          79
          value
          55
        3. group Id
          BG002
          lower Limit
          21
          upper Limit
          80
          value
          56
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          32
        3. group Id
          BG002
          value
          52
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          77
        2. group Id
          BG001
          value
          74
        3. group Id
          BG002
          value
          151
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
Eligible patients who started protocol treatment and did not withdraw consent.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice